Clinical Trial Update: Individualized Neuromodulation of Craving Control for Meth Use Disorders [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial investigating individualized neuromodulation to control cravings in methamphetamine use disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Substance Use Disorder

Snippet

Sponsor: University of Minnesota | Conditions: Substance Use Disorders, Methamphetamine Use Disorders | EARLY_Phase 1 | Status: WITHDRAWN